Salivary α-Amylase as a Metabolic Biomarker: Analytical Tools, Challenges, and Clinical Perspectives.
Level 5 - mechanism / opinion, no new human data
Narrative review of analytical methods and physiological mechanisms with no systematic synthesis or original data
PubMed 40806495 · doi:10.3390/ijms26157365
What was done
This review examined the physiological role and analytical methodologies for measuring salivary α-amylase (primarily encoded by the AMY1 gene) as a potential metabolic biomarker. The authors evaluated current quantification techniques (enzymatic assays, colorimetric methods, immunoassays, and biosensors) alongside pre-analytical and analytical challenges, including sample collection, intra-individual variability, and assay standardization.
What was found
The abstract reports no numerical findings or statistical measures. Qualitatively, it highlights that salivary amylase activity correlates with AMY1 copy number variation and is linked to postprandial glycemic control, insulin secretion dynamics, visceral adiposity, and obesity risk.
Why it matters
Measuring salivary amylase could provide a non-invasive tool to stratify obesity risk and design personalized dietary starch interventions if methodological and standardization hurdles are resolved.
Limits
As a narrative review, it presents no original empirical data, quantitative meta-analysis, or systematic search methodology. The abstract omits diagnostic accuracy metrics, reference ranges, and specific performance benchmarks for the discussed analytical platforms.
Cited by
- supports Salivary amylase breaks down dietary starch into simple sugars.